Related Experiment Videos
A comparative study of classical vs. desmoplastic medulloblastomas.
P Pramanik1, M C Sharma, P Mukhopadhyay
1Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Neurology India
|July 17, 2003
Summary
Classical and desmoplastic medulloblastomas (MBs) show no significant differences in biological aggressiveness markers or clinical outcomes. Histological variants do not correlate with medulloblastoma growth rate or patient survival.
Area of Science:
- Pediatric Oncology
- Neuropathology
- Molecular Biology
Background:
- Medulloblastomas (MBs) are pediatric brain tumors with distinct histological variants.
- Classical and desmoplastic MBs are suspected to differ biologically, but comparative data on aggressiveness markers are limited.
Purpose of the Study:
- To compare biological aggressiveness markers between classical and desmoplastic medulloblastoma variants.
- To determine if histological type influences clinical outcomes and tumor behavior.
Main Methods:
- Retrospective analysis of 87 classical and 43 desmoplastic MB cases.
- Evaluation of clinical and histological characteristics, MIB-1 labeling index, apoptotic index, p53, and Bcl-2 expression.
- Assessment of 3-year progression-free survival.
Main Results:
- Differences were observed in age distribution and tumor location between variants.
- No significant differences were found in proliferation index, apoptotic index, or molecular markers (p53, Bcl-2).
- Progression-free survival did not differ significantly between classical and desmoplastic MBs.
Conclusions:
- Classical and desmoplastic medulloblastomas do not exhibit significant differences in biological aggressiveness parameters.
- Histological variant is not correlated with medulloblastoma growth rate or clinical outcome.